Directory at Vanderbilt-Ingram Cancer Center
Search or browse for cancer center researchers, leadership and key staff by last name, research program or department.
The Breast Cancer Program has expertise in and leads clinical trials related to:
ER-Positive Breast Cancer
Identifying the role of PI3K inhibitors in resistance to antiestrogens in ER+ breast cancer
Triple-Negative Breast Cancer
Molecular sub-classification of triple negative breast cancer and discovery of novel treatment targets
Evaluating non-invasive imaging technologies to predict anti-cancer drug action and treatment response
Breast Development & Disease
Studying the role of ERBB3 in mammary gland development, transformation and adaptive resistance
Cancer Stem Cells
Understanding the role of TGFβ in cancer stem-like behavior and tumor progression
Disparities & Risk Factors
Investigating obesity as a metabolic marker of breast cancer risk in African Americans
Discovering actionable therapy targets in drug-resistant breast tumors after neoadjuvant therapy
Leading innovative clinical trials with targeted therapies and combinations
The Translational Research and Interventional Oncology program is dedicated to translating our understanding of the molecular mechanisms of oncogenesis and tumor progression into novel therapeutic strategies for cancer.
Early Phase Trials
Developing early phase clinical trials for therapies directed at genetic changes in tumors
Investigating why some tumors become resistant to genetically targeted therapies and developing new strategies to prevent and overcome resistance
Immune & Cellular Therapy
Applying and enhancing immune strategies and cellular therapies for cancer
Developing and evaluating screening methods and biomarkers for early detection of lung cancers
Search at Vanderbilt-Ingram Cancer Center
Fundraising to support discovery grants at Vanderbilt-Ingram Cancer Center.
By personally supporting and raising funds for grants through the Victory Over Cancer fund, the Ambassadors spark the beginning of new major research initiatives.
Advocating for Vanderbilt-Ingram Cancer Center.
Through their personal and professional networks, the Ambassadors spread the word about how Vanderbilt-Ingram is leading the way in cancer treatment and research and work to identify and recruit new Ambassadors.
Participating in the Vanderbilt-Ingram Cancer Center community.
The VICC Ambassadors support the services provided at Vanderbilt-Ingram as active members of the community through attending meetings and events, hearing from Vanderbilt-Ingram leaders and partnering with Medical Center Development staff.
Meet the VICC Ambassadors
Visit each Ambassador’s page to learn more about why they have joined VICC Ambassadors and how you can support their individual goals in the fight against cancer.
Other Ways To Give
If you wish to make a general gift to support the Ambassadors' mission, please choose one of these options:
The SPORE in Breast Cancer
Vanderbilt-Ingram Cancer Center's SPORE in Breast Cancer, established in 2003, is one of only five in the country, and focuses on innovative, translational research for better diagnosis, prognosis, screening, prevention and treatment of breast cancer.
The Vanderbilt-Ingram Cancer Center SPORE in Breast Cancer has established a true multidisciplinary program focused on conducting multidisciplinary, mechanism-based, translational research of the highest possible impact that will contribute meaningfully to measurable progress in breast cancer. Our investigators have expertise in cellular signaling and molecular biology, breast pathology, medical, surgical, and radiation oncology, clinical trial design, epidemiology and population studies, mass spectrometry, biostatistics, and biomedical informatics.
The Breast SPORE supports several initiatives including four scientific research projects, five cores that provide essential services to SPORE projects, a developmental research program to support pilot projects, and career development opportunities for physician-scientists in training.
Breast SPORE Research Projects
The SPORE in Breast Cancer supports four research projects aimed at addressing basic, clinical and population research questions of importance in human breast cancer. All projects are translational and multidisciplinary and are led by co-investigators from multiple departments across the School of Medicine, with complementary basic science and translational/clinical expertise.
Learn more about our Breast SPORE research projects and cores.
Mechanisms of Resistance to Endocrine Therapy in ER+ Breast Cancer
- Clinical co-leader: Brent Rexer, MD, PhD
- Basic co-leader: Carlos L. Arteaga, MD
- Basic co-investigator: Ariella Hanker, PhD
- Clinical co-investigator: Ingrid A. Mayer, MD, MSCI
- Patient advocate: Janet Piper
Strategies to Improve Outcomes for Triple-Negative Breast Cancer Patients Integrating Subtype-Specific Genomic and Immune-Based Discoveries
- Clinical co-leader: Vandana G. Abramson, MD
- Basic co-leader: Jennifer A. Pietenpol, PhD
- Basic co-investigators: Brian Lehmann, PhD and Alissa Weaver, MD, PhD
- Patient advocate: Patricia [Patty] Lee
Targeting the DNA Damage Response in Breast Cancer
- Clinical co-leader: Vandana Abramson, MD
- Basic co-leader: David Cortez, PhD
- Basic co-investigators: Violeta Serra, PhD, Kimberly Dahlman, PhD, Deborah Lannigan, PhD and Mark O’Connor, PhD
- Patient advocate: Lynn Cargen
Targeting Antigen Presentation to Improve Immunotherapy Responses in Breast Cancer
- Clinical co-leader: Ingrid A. Mayer, MD, MSCI
- Basic co-leader: Justin M. Balko, PharmD, PhD
- Basic co-investigator: Brent Ferrell, MD
- Patient advocate: Linda Horton